Literature DB >> 8046432

New genotype of hepatitis C virus in South Africa.

T Ohno1, M Mizokami, C J Tibbs, K Ohba, K Suzuki, R R Wu, K T Nouri-Aria, R Williams.   

Abstract

Partial nucleotide sequences in the core region of the hepatitis C viral genome were determined by reverse transcription followed by polymerase chain reaction, in a patient with chronic hepatitis from South Africa. These nucleotide sequences showed a low degree of homology with known types of HCV: the degree of homology between the nucleotide sequences of these clones with HC-J1, J4, J6, J7, Tr, and Eb-1 were 86.1-87.3%, 87.3-87.9%, 83.0-83.9%, 81.1-82.0%, 81.0-82.2%, and 82.8-83.4%, respectively, and that the deduced amino acid sequence homologies between these clones and HC-J1, J4, H6, J7, Tr, and Eb-1 were 90.7-91.6%, 89.7-91.6%, 91.6-93.5%, 90.7-91.6%, 81.5-82.4%, and 89.2-90.2%, respectively. The nucleotide sequence homologies of these clones with HC-J1, J4, J6, J7, Tr, and Eb-1 were very low, compared to those between the same genotype. Further comparison using molecular evolutionary methods suggested that this sequences should be classified in a new genotype.

Entities:  

Mesh:

Year:  1994        PMID: 8046432     DOI: 10.1002/jmv.1890420414

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Assessment of commercial enzyme immunoassay for hepatitis C virus serotyping.

Authors:  L M Webber; S Els; M B Taylor; W O Grabow
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

Review 2.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 3.  New developments in small molecular compounds for anti-hepatitis C virus (HCV) therapy.

Authors:  Jing Tong; You-wei Wang; Yuan-an Lu
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

4.  New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a.

Authors:  O Ohno; M Mizokami; R R Wu; M G Saleh; K Ohba; E Orito; M Mukaide; R Williams; J Y Lau
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Genotyping of hepatitis C virus in South Africa.

Authors:  H E Smuts; J Kannemeyer
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients.

Authors:  T Ohno; M Mizokami; M G Saleh; E Orito; K I Ohba; R R Wu; T Koide; C J Tibbs; K T Nouri-Aria; S Tokudome; R Williams
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  HCV genotypes in Swedish blood donors as correlated to epidemiology, liver disease and hepatitis C virus antibody profile.

Authors:  S Shev; A Widell; U Foberg; A Frydén; S Hermodsson; G Lindh; A Lindholm; S Månsson; O Weiland; G Norkrans
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

8.  Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus.

Authors:  T Ohno; M Mizokami; M Yamauchi; K Ohba; E Orito; R R Wu; M Mizuno; K Sugihara; T Wakita; S Kakumu
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

Review 9.  [Characteristics of the hepatitis C virus and viral predictors of therapeutic response].

Authors:  A Ambrosch; W König
Journal:  Med Klin (Munich)       Date:  1999-11-15

Review 10.  Virology of hepatitis C virus.

Authors:  P Simmonds
Journal:  Clin Ther       Date:  1996       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.